Dividend Calendar: Week of July 13, 2026

The week of July 13, 2026 presents dividend investors with a diverse selection of income opportunities across multiple sectors. Fifteen notable companies are scheduled to go ex-dividend, featuring yields ranging from 2.04% to 7.12%. Healthcare and telecommunications stocks dominate the high-yield segment, while consumer staples and energy companies provide solid mid-range dividend options.

Ex-Dividend Dates This Week

Companies going ex-dividend during the week of July 13, 2026 span various industries, offering income investors multiple opportunities to capture quarterly distributions. The following table details each company’s dividend specifications:

High-Yield Dividend Opportunities

Pfizer leads this week’s dividend calendar with a substantial 7.12% yield on its $1.72 quarterly distribution. The pharmaceutical giant’s elevated yield reflects both its commitment to shareholder returns and current market valuation dynamics. Telecommunications companies Verizon and AT&T follow with yields of 6.64% and 5.25% respectively, continuing their tradition of providing reliable income streams to dividend-focused investors.

Bristol-Myers Squibb rounds out the above-4% yield category at 4.36%, offering another healthcare dividend option. These higher-yielding stocks may appeal to income investors seeking enhanced cash flow, though yields should be evaluated alongside each company’s dividend sustainability and business fundamentals.

Blue-Chip Dividend Stalwarts

Several dividend aristocrats and long-term dividend payers feature prominently this week. PepsiCo offers a 4.18% yield with its $5.75 quarterly payment, while energy major Chevron provides a 3.96% yield through its $6.98 distribution. Consumer goods leader Procter & Gamble maintains its consistent dividend policy with a $4.26 payment yielding 2.90%.

Johnson & Johnson, despite offering the lowest yield at 2.04%, represents decades of consecutive dividend increases and remains a cornerstone holding for many dividend growth portfolios. The healthcare conglomerate’s $5.24 quarterly payment reflects its stable cash generation and commitment to shareholder returns across market cycles.

How to Use This Dividend Calendar

The ex-dividend date is the critical deadline for capturing a company’s upcoming dividend payment. To receive the distribution, an investor must own shares before the ex-dividend date — buying on or after the ex-date means missing the upcoming payment. Settlement cycles in U.S. equity markets now follow a T+1 standard (shortened from T+2 in May 2024), so most brokerages require purchase at least one business day before the record date.

For each stock listed above, the ex-dividend and pay dates are marked “TBD” pending official company announcements. Investors should monitor each company’s investor-relations page or SEC filings (Form 6-K for foreign issuers, 8-K for domestic) for confirmed dates as the week approaches. The KabuWire team updates these fields as soon as companies formally declare their ex-dividend schedules.

Sector Concentration Analysis

This week’s 15 ex-dividend names cluster heavily in three sectors that traditionally dominate dividend distributions:

• Healthcare (6 names): Pfizer, Bristol-Myers Squibb, Merck, AbbVie, Johnson & Johnson, and Gilead Sciences — together representing roughly 40% of the week’s calendar. Healthcare’s dividend weight reflects mature cash flows, established product lines, and a sector-wide preference for returning capital to shareholders via distributions rather than buybacks.
• Financials (3 names): U.S. Bancorp, Wells Fargo, plus the broader financial-services complex visible in this week’s roster. Bank dividends tend to track net-interest-margin cycles and Federal Reserve capital rules; investors should verify that each bank has cleared its most recent stress test before relying on the announced payout.
• Consumer Staples & Energy (4 names): PepsiCo, Procter & Gamble, Coca-Cola, Chevron, and Exxon Mobil — classic dividend-aristocrat names whose payouts have survived multiple economic cycles. Energy-sector dividends in particular are sensitive to crude-price movements, so the current week’s calendar should be read against the prevailing oil-price backdrop.

Telecommunications (Verizon, AT&T) round out the list as yield-oriented income plays. The remaining names span technology-adjacent and industrial sectors in smaller weightings.

Yield Tiers and Risk Considerations

The week’s yields fall into three distinct tiers worth examining separately:

Tier 1 — Above 5% (high yield): Pfizer (7.12%), Verizon (6.64%), and AT&T (5.25%). Yields at this level typically signal one of three things: a depressed share price relative to the dividend, a leveraged balance sheet, or a sector with structural headwinds (telecom capex, pharmaceutical patent cliffs). Investors should evaluate payout ratio, free cash flow coverage, and forward earnings guidance before treating these as core income holdings.

Tier 2 — 3% to 5% (mid yield): Bristol-Myers Squibb (4.36%), PepsiCo (4.18%), Chevron (3.96%), and U.S. Bancorp (3.33%). This tier often represents the sweet spot for income-and-growth portfolios — yields high enough to matter, but not so high as to flag sustainability concerns.

Tier 3 — Below 3% (quality compounder): Exxon Mobil, Procter & Gamble, Merck, AbbVie, Coca-Cola, Gilead Sciences, Wells Fargo, and Johnson & Johnson. Lower yields in this group reflect premium valuations rather than weak payouts — Johnson & Johnson’s 2.04% yield on a $5.24 quarterly payment, for instance, represents decades of consecutive dividend increases against a steadily rising share price.

Timing the Ex-Dividend Trade

A common retail-investor mistake is to chase high-yield names into their ex-dividend date, then watch the share price drop by the dividend amount on the next open. This is the mechanical “ex-dividend price drop” — the market routinely re-prices shares lower by approximately the dividend amount on the ex-date because new buyers no longer receive the upcoming payment. The trade is therefore not “buy before ex-date, sell after ex-date” for a free dividend; it is a wash when accounting for the price drop.

For long-term dividend investors, the practical guidance is to build positions well before the ex-date and hold through the payment rather than trying to time around it. For shorter-horizon traders, the more relevant signal is often the company’s earnings calendar relative to its dividend declaration — a positive earnings surprise combined with a maintained or raised dividend is typically a stronger catalyst than the ex-date itself.

This dividend calendar is for informational purposes only and does not constitute investment advice. Dividend payments and yields are subject to change, and investors should verify all information with official company sources before making investment decisions. Past dividend performance does not guarantee future payments.